Table 1 Patient characteristics, injected doses, and summary pathology classification
Subject | Age | Prostate volume (cc) | PSA (ng/mL) | Subject Weight (kg) | Injected dose (MBq) | Number of lesions | Lesion location (Gleason grade group) |
|---|---|---|---|---|---|---|---|
1 | 69 | 35.2 | 9.6 | 108.4 | 183.2 | 1 | RTZ (2), RCZ (1) |
2 | 62 | 36.1 | 20.6 | 132.0 | 180.6 | 1 | LPZ (3) |
3 | 69 | 60 | 9.8 | 76.2 | 183.5 | 1 | RCZ (4), RPZ (3) |
4 | 69 | 39.1 | 5.6 | 97.5 | 183.2 | 1 | LPZ (3) |
5 | 63 | 30 | 4.2 | 79.4 | 181.3 | 1 | LPZ (2) |
6 | 57 | 28.5 | 5.6 | 90.7 | 170.6 | 1 | RPZ (2) |
7 | 52 | 27.3 | 6.2 | 111.1 | 171.7 | 2 | RTZ (2), RPZ (2), LTZ (2) |
8 | 57 | 51 | 10.8 | 108.0 | 182.4 | 2 | LCZ (2), LTZ (2), RPZ (2) |
9 | 64 | 43.8 | 4.8 | 83.9 | 185.0 | 1 | RPZ (3) |
10 | 66 | 59.4 | 18.5 | 88.5 | 185.0 | 1 | LPZ (3) |
11 | 53 | 37.9 | 9.2 | 91.2 | 183.9 | 1 | LCZ (3) |
12 | 69 | 66.5 | 8.7 | 63.5 | 184.6 | 1 | LPZ (3) |
13 | 60 | 41.6 | 4.5 | 92.1 | 186.1 | 1 | RPZ (2) |
14 | 75 | 37.4 | 6.6 | 81.7 | 184.6 | 1 | LPZ (2) |
15 | 58 | 62.8 | 6.7 | 112.0 | 185.7 | 1 | RPZ (2) |
16 | 66 | 41.9 | 6.8 | 90.7 | 183.2 | 2 | LCZ (2), RPZ (1) |
17 | 66 | 89.4 | 7.3 | 69.0 | 184.3 | 2 | RTZ (2), RPZ (2) |
18 | 67 | 72.6 | 4.1 | 88.0 | 183.5 | 2 | RPZ (2) |